Status:
COMPLETED
Innovative Strategies For Risk Reduction Following CABG
Lead Sponsor:
Unity Health Toronto
Collaborating Sponsors:
Canadian Diabetes Association
Conditions:
Coronary Artery Disease
Type II Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Background: Treatment targets for cardiac risk factor reduction are not being met. Therefore, there is a need for new strategies to assist patients in meeting these goals. Objective: To determine the...
Detailed Description
Introduction: The consumption of a dietary portfolio has been found to successfully reduce LDL cholesterol by 30% in hyperlipidemic, non-diabetic patients under highly controlled conditions. Given the...
Eligibility Criteria
Inclusion
- Patients with type II diabetes mellitus
- Recently (\<5 months) undergone coronary artery bypass graft surgery
- Taking cholesterol lowering medication
Exclusion
- Can not speak English and have no available interpreter
- Refuse Informed Consent
- Had "off pump" CABG
- Are intolerant of statins
- Are pre-menopausal (women) or are on HRT
- Have serious concomitant disease
- Take insulin
- Are \<18 years of age
- receive incomplete revascularization
- documented history of drug or alcohol abuse
- Intend to become pregnant during study period
- Have an unreliable psychological condition that makes them unlikely to comply
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2010
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00462436
Start Date
February 1 2007
End Date
May 1 2010
Last Update
July 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Michael's Hospital
Toronto, Ontario, Canada, M5B 1W8